Design Therapeutics (NASDAQ:DSGN – Get Free Report) and Alzamend Neuro (NASDAQ:ALZN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends. Risk & Volatility Design Therapeutics has a […]
Form N-CSR BlackRock Capital Apprec For: May 31 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CARLSBAD, Calif., May 31, 2023 Design Therapeutics, Inc. , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today reported that management. | May 31, 2023